AEON vs BIIB: Which Stock is Better?
Side-by-side comparison of Aeon Biopharma Inc and Biogen Inc in 2026
AEON
Aeon Biopharma Inc
$1.20
BIIB
Biogen Inc
$165.38
Key Metrics Comparison
| Metric | AEON | BIIB | Winner |
|---|---|---|---|
| Market Cap | $10.95M | $24.26B | BIIB |
| P/E Ratio | N/A | 15.09 | BIIB |
| EPS (TTM) | $N/A | $10.96 | BIIB |
| Revenue Growth | 0.0% | 0.0% | BIIB |
| Gross Margin | 0.0% | 76.6% | BIIB |
Analyze AEON
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is AEON or BIIB a better investment?
Comparing AEON and BIIB: Aeon Biopharma Inc has a market cap of $10.95M while Biogen Inc has $24.26B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between AEON and BIIB?
AEON (Aeon Biopharma Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: AEON or BIIB?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: AEON or BIIB?
BIIB has higher revenue growth at 0.0% vs 0.0% for AEON.
Which company is more profitable: AEON or BIIB?
Biogen Inc (BIIB) has higher gross margins at 76.6% compared to 0.0% for AEON.
Which is the larger company: AEON or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $24.26B compared to $10.95M for AEON.
Should I buy AEON or BIIB in 2026?
Both AEON and BIIB have investment merit. AEON trades at $1.20 while BIIB trades at $165.38. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between AEON and BIIB stock?
Key differences: Market Cap ($10.95M vs $24.26B), P/E Ratio (N/A vs 15.1x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 76.6%).